Leo put out quite a few PRs last year. Many some would consider mundane, fluff, whatever. Does anyone else find it odd that a few items in the 10q were not PRed prior to this filing? The AS completion of their P1 is one example. This isn’t a criticism of Leo at all. My gut tells me there is a reason. Just not quite sure what it is. But it seems Leo is being uncharacteristically quiet. Even the fact that there hasn’t been a PR in regard to the filing itself, has me asking myself questions. Something....perhaps expanding on the AS P1 trial...
Maybe I’m overthinking. Just wondering what anybody else’s thoughts are.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links